Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients

Authors

DOI:

https://doi.org/10.15407/dopovidi2021.05.114

Keywords:

Insulin receptor substrate-1, COVID-19, diabetes mellitus, cardiovascular diseases

Abstract

Insulin receptor substrate (IRS) is a key adapter protein mediating effects of insulin and insulin-like growth factors (IGF) in cells. IRS-1 is a member of the insulin receptor substrate family, which is associated with tumor initiation and progression. The aim of the study is to determine the level of IRS-1 in the blood of patients (n = 81) with diabetes mellitus and COVID-19. IRS-1 was determined with enzyme-linked immunosorbent assay (ELISA) (Elabscience, USA). The measurements were performed at an optical wavelength of 450 nm. The level of IRS-1 in the blood plasma of patients with COVID-19 was much (from 3.5 to more than 6 times) higher than that in the blood of healthy people. The IRS-1 amounts in COVID-19 patients with diabetes and diabetes + CVD were significantly higher than in patients with COVID-19 without concomitant diseases. The level of IRS-1 in blood plasma may be one of the promising markers of COVID-19.

References

Tronko, N. D., Pushkarev, V. M., Sokolova, L. K., Pushkarev, V. V. & Kovzun, O. I. (2018). Molecular mechanisms of pathogenesis of diabetes and its complications. Kyiv: Publishing house Medkniga (in Russian).

Tronko, N. D., Kovzun, E. I., Pushkarev, V. V., Sokolova, L. K. & Pushkarev, V. M. (2018). Reception and intracellular mechanisms of insulin action (рart 1). Endokrynologia, 23, No. 3, pp. 269-280 (in Russian).

Semple, R. K. (2016). EJE PRIZE 2016: How does insulin resistance arise, and how does it cause disease? Human genetic lessons. Eur. J. Endocrinol., 174, No. 5, pp. R209-223.

Esposito, D. L., Aru, F., Lattanzio, R., Morgano, A., Abbondanza, M., Malekzadeh, R., Bishehsari, F., Valanzano, R., Russo, A., Piantelli, M., Moschetta, A., Lotti, L. V. & Mariani-Costantini, R. (2012). The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer. PLoS One, 7, pp. e36190.

Porter, H. A., Perry, A., Kingsley, C., Tran, N. L. & Keegan, A. D. (2013). IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors. Cancer Lett., 338, pp. 239-248.

Luo, J., Wen, Q., Li, J., Xu, L., Chu, S., Wang, W., Shi, L., Xie, G., Huang, D. & Fan, S. (2014). Increased expression of IRS-1 is associated with lymph node metastasis in nasopharyngeal carcinoma. Int. J. Clin. Exp. Pathol., 7, pp. 6117-6124.

Sun, X., Chen, Y., Tan, J. & Qi, X. (2018). Serum IRS-1 acts as a novel biomarker for diagnosis in patients with nasopharyngeal carcinoma. Int. J. Clin. Exp. Pathol., 11, No. 7, pp. 3685-3690.

Chan, S. H., Kikkawa, U., Matsuzaki, H., Chen, J. H. & Chang, W. C. (2012). Insulin receptor substrate-1 prevents autophagy-dependent cell death caused by oxidative stress in mouse NIH/3T3 cells. J. Biomed. Sci., 19, pp. 64.

Hakuno, F., Fukushima, T., Yoneyama, Y., Kamei, H., Ozoe, A., Yoshihara, H., Yamanaka, D., Shibano, T., Sone-Yonezawa, M., Yu, B. C., Chida, K. & Takahashi, S. (2015). The novel functions of high-molecular-mass complexes containing insulin receptor substrates in mediation and modulation of insulin-like activities:emerging concept of diverse functions by IRS-associated proteins. Front. Endocrinol. (Lausanne), 6, pp. 73. https://doi.org/10.3389/fendo.2015.00073

Reuveni, H., Flashner-Abramson, E., Steiner, L., Makedonski, K., Song, R., Shir, A., Herlyn, M., Bar-Eli, M. & Levitzki, A. (2013). Therapeutic destruction of insulin receptor substrates for cancer treatment. Cancer Res., 73, No. 14, pp. 4383-4394. https://doi.org/10.1158/0008-5472.CAN-12-3385

Mardilovich, K., Pankratz, S. L. & Shaw, L. M. (2009). Expression and function of the insulin receptor substrate proteins in cancer. Cell Commun. Signal., 7, pp. 14. https://doi.org/10.1186/1478-811X-7-14

Downloads

Published

27.10.2021

How to Cite

Tronko, M. D., Pushkarev, V. V., Sokolova, L. K., Cherviakova, S. A., Belchina, Y. B., Kovzun, O. I., & Pushkarev, V. M. (2021). Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients. Reports of the National Academy of Sciences of Ukraine, (5), 114–117. https://doi.org/10.15407/dopovidi2021.05.114